Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Classical hematology 1

Conditions

Leukemia, Myelomonocytic, Chronic 2Leukemia 2Anemia, Refractory, with Excess of Blasts 2Anemia 2beta-Thalassemia 1Thrombocytopenia 1Thalassemia 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Myelodysplastic Syndromes 1Multiple Myeloma 1Fatigue 1Anemia, Sickle Cell 1Anemia, Refractory 1

Interventions

Epoetin Alfa 3Surveys and Questionnaires 2Darbepoetin alfa 2stinging nettle lectin 1peppermint oil 1ofatumumab 1epoetin beta 1Sodium Chloride 1Ritonavir 1Quality of Life 1Physical Therapy Modalities 1Metformin 1Lenalidomide 1Holistic Health 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Dexamethasone × Classical hematology × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡